Quality of life in peritoneal carcinomatosis: a prospective study in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC).

@article{Albertsmeier2014QualityOL,
  title={Quality of life in peritoneal carcinomatosis: a prospective study in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC).},
  author={Markus Albertsmeier and Alexandra Hauer and Hanno Niess and Jens Werner and Christian Graeb and Martin Kurt Angele},
  journal={Digestive surgery},
  year={2014},
  volume={31 4-5},
  pages={334-40}
}
BACKGROUND/AIMS Cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion (HIPEC) can improve survival in selected patients with peritoneal carcinomatosis, but bear a significant risk of perioperative morbidity. The aim of this study was to prospectively evaluate the quality of life (QoL) following cytoreduction and HIPEC. METHODS In this study including 40 patients (65% females) with different primary tumors, the EORTC QLQ-C30 questionnaire was applied prior to CS and HIPEC as… CONTINUE READING